Search Results
220 items found for "cancer biology"
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
Authors Chenshen Huang , Fengshuo Zhu , Hao Zhang , Ning Wang , Qi Huang Tags Cancer , Machine learning , Molecular biology Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR
- CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
The CC chemokine receptor 6 (CCR6) is a G protein-coupled receptor (GPCR) involved in a wide range of biological This pathway is implicated in mechanisms related to many diseases, such as cancer, psoriasis, multiple
- GPR4 in the pH-dependent migration of melanoma cells in the tumor microenvironment
2022 Abstract Due to its high metastatic potential, malignant melanoma is one of the deadliest skin cancers In melanoma as well as in other cancers, acidification of the tumor microenvironment (= TME, inverse
- Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
receptor (GPCR) that is involved in a variety of pathological and physiological processes, while its biological The lung cancer cell line H1299-BRS3 was treated with MK-5046, an agonist of BRS3, for different durations
- From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction
protein-coupled receptors (GPCRs), enhancing proliferation, adhesion, and migration in many types of cancer Our group previously reported that LPA induces production of CCN1 protein in human prostate cancer cell
- Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Avila Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung cancer-mutations
- CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
Dysregulation of prenylation contributes to multiple disorders, including cancers and vascular and neurodegenerative repurposing statins as Ras oncogene inhibitors and the failure of using prenyltransferase inhibitors in cancer
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
Published date October 23, 2023 Abstract Glioblastoma multiforme (GBM) is one of the most aggressive cancers We used The Cancer Genome Atlas (TCGA) GBM genomic dataset to identify differentially expressed genes
- Ep 150 with Dr GPCR Team
Monserrat Avila Zozaya I did a PhD in cell biology at CINVESTAV, Mexico. During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery Biology
- Ep 38 with Dr. Alexander S. Hauser
currently a postdoc as a member of the personalized medicine cluster in Copenhagen and at the Institute of Biological Alexander has a big interest in the integration of large biomedical data in genomics, structural biology and pharmacoepidemiology with innovative computational methods to gain novel insights into receptor biology Alexander had a research sabbatical with Madan Babu at the MRC Laboratory of Molecular Biology in Cambridge
- Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target
However, the role of β2-AR in oral cancer is not well identified. Kumar Mohanty, Rajender Singh, Vijay Kumar, Uma Shankar Singh, Rakesh Kumar Singh Tags GPCR; OSCC; Oral cancer
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
., Departments of Neuroscience and Biochemistry & Molecular Biology, Baylor College of Medicine, Houston of Medicine, where he studies BAI1's role in the brain and the radiobiology of treatments for brain cancer
- Ep 46 with Dr Gunnar Schulte
Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology Melbourne Australia, GPCR pharmacology; 2006) before starting his independent research team "Receptor Biology Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological is on Frizzled signaling and pharmacology aiming to understand the role of WNT/Frizzled signaling in biology
- Ep 58 with Dr. Juan José Fung
Scientist at GPCR Therapeutics, Inc , a drug discovery company focused on targeting GPCR heteromers in cancer
- Ep 155 with Endocrine Metabolic GPCR Organizers
She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Alejandra Tomas is a molecular cell biologist and Senior Lecturer at the Department of Metabolism, Digestion
- Ep 107 with Dr. Roger Sunahara
strong foundation and appreciation for the applications of pharmacology, biochemistry and structural biology speculate that these aberrations in Galpha-s(l), specifically, may be involved in other pathologies such as cancer
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
Patients' data on HCC were sourced from the Liver Hepatocellular Carcinoma-Japan (LIRI-JP) and The Cancer immunotherapy and common antitumor drugs was predicted via the database Genomics of Drug Sensitivity in Cancer
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
His research experience includes phylogenetics and cancer epigenetics.
- Ep 157 with Dr. Nagarajan Vaidehi
She is also the Associate Director of the City of Hope Comprehensive Cancer Center. Dr.
- Ep 73 with Dr. Aylin Hanyaloglu
She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes
- Ep 18 with Dr. Yamina Berchiche
The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide G protein-coupled receptors (GPCRs) mediate a vast variety of critical biological processes and provide quantitative, and multi‐scale integration of these amounts of data to gain novel insights into receptor biology
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
Lorazepam, which has off target agonism of GPR68, is linked to worse clinical outcomes for a variety of cancers However, the role of tumor microenvironment acidification in GPR68 activation has not been assessed in cancer
- Ep 136 with Murat Tunaboylu & Ben Holland
After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer
- Ep 77 with Martin Audet
Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke located at the Institute of Pharmacology of Sherbrooke and is an emerging leader in the structural biology
- Ep 92 with Dr. Stephane Angers
development of novel antibody molecules blocking and activating the Wnt pathway for the treatment of cancers
- Ep 23 with Dr. Qing Fan
Fan is currently an associate professor of Pharmacology and Pathology and Cell Biology at Columbia University Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
non-cleavable point mutant knock-in mouse, H381S Jesse Stillwell Next Generation MBD2 inhibitors for Brain Cancer during prolonged cold exposure Caroline Formstone Interrogating The Role Of CELSR1 (ADGRC1) In Breast Cancer Discovery for Human Adhesion GPCRs Tyler Bernadyn Elucidating The Role Of GPR97/ADGRG3 In Neutrophil Biology
- High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro
Previous studies have indicated that GPR50 could protect against breast cancer development and decrease